Header Logo

Connection

KONSTANTIN TSOYI to Neovascularization, Pathologic

Back to Details
This is a "connection" page, showing publications KONSTANTIN TSOYI has written about Neovascularization, Pathologic.
KONSTANTIN TSOYI
Connection Strength
0.054
Neovascularization, Pathologic
  1. QM107, a novel CD148 (RTP Type J) activating peptide therapy for treating neovascular age-related macular degeneration. Br J Pharmacol. 2025 Feb; 182(4):951-968.
    View in: PubMed
    Score: 0.054
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.